4th Quarter - Report

SLC HEALTH STRATEGIES, LLC for NOVO NORDISK PHARMACEUTICALS, INC.

Firm
Client
Income
$27,000
Expenses
—

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

National Diabetes Prevention Program funding -- S 1284 - Department of Labor, Health and Human Services and Education and Related Agencies Appropriations Act of 2014 Implementation of the Affordable Care and Health Care & Education Affordability Reconciliation Act of 2010 (PL 111-148 and 111-152); diabetes screening Human growth hormone and rare disease matters HR 1074/S 539 - National Diabetes Clinical Care Commission Act of 2013 HR 1247/S 945 - Access to Quality Diabetes Education Act of 2013 HR 1915/S 907 - Gestational Diabetes Act of 2013

LobbyistCovered position, as disclosed
SHARON COHEN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 1247 (113th), H.R. 1074 (113th), H.R. 1915 (113th)

Medicare/Medicaid MMM

FY 2014 Omnibus HR 3547 FY 2014 Continuing Resolution H J Res 106 PL 113-73 FY 2014 Continuing Resolution H J Res 59 PL 113-67 HR 4302 SGR Patch Protecting Access to Medicare Act of 2014 - Public Law No: 113-93 In all of the above the specific issues included potential Medicare offsets that might be applied to prescription drugs HR 962/S 452 - Medicare Diabetes Prevention Act of 2013 HR 1257 Prevent Diabetes Medicare Act of 2013 HR 1274/S 945 Access to Quality Diabetes Education Act of 2013; HR 1588/ S 740 -- Medicare Drug Savings Act of 2013 HR 2415/ S 1184 - Treat and Reduce Obesity Act of 2013; HR 2663/S 1422 - Scoring of Preventive Health Savings Medicare diabetes screening and self management

LobbyistCovered position, as disclosed
SHARON COHEN —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 1257 (113th), H.R. 2415 (113th), H.R. 962 (113th), H.R. 1588 (113th), H.R. 1274 (113th), H.R. 3547 (113th), H.J.Res. 59 (113th), H.R. 4302 (113th), H.J.Res. 106 (113th), H.R. 2663 (113th)

Budget/Appropriations BUD

FY 2014 Omnibus HR 3547 FY 2014 Continuing Resolution H J Res 106 PL 113-73 FY 2014 Continuing Resolution H J Res 59 PL 113-67 HR 4302 SGR Patch Protecting Access to Medicare Act of 2014 - Public Law No: 113-93 In all of the above the specific issues included potential Medicare offsets that might be applied to prescription drugs HR 962/S 452 Medicare Diabetes Prevention Act of 2013; HR 1257 - Prevent Diabetes in Medicare Act of 2013; HR 1247/S 945 - Access to Quality Diabetes Education Act of 2013; HR 2663/ S 1422 Scoring of Preventive Health Savings; and S 1284 - Department of Labor, Health and Human Services and Education and Related Agencies Appropriations Act of 2014, specifically NDPP funding HR 83 - Consolidated and Further Continuing Appropriations Act, 2015

LobbyistCovered position, as disclosed
SHARON COHEN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 1247 (113th), H.J.Res. 59 (113th), H.R. 3547 (113th), H.R. 2663 (113th), H.J.Res. 106 (113th), H.R. 962 (113th), H.R. 1257 (113th), H.R. 83 (113th), H.R. 4302 (113th)

Pharmacy PHA

FDA issues regarding biosimilar products; 340B program matters

LobbyistCovered position, as disclosed
SHARON COHEN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.